Switzerland

Georg Fischer AG (GF), a Swiss industrial company listed at SIX Swiss Exchange (ticker: GF) has completed the divestment of its iron foundry in Leipzig (Germany) to Linamar Corp., a global manufacturer of advanced mobility and industrial solutions headquartered in Canada, effective end of day on 31 December 2025. The successful closing represents one of the final steps in GF’s transformation into a pure-play Flow Solutions company. The transaction value amounts to approximately EUR 45 million. With the closing, the iron foundry’s around 300 employees and operations in Leipzig transfer to Linamar. The foundry was previously part of the GF Casting Solutions division, for which a divestment agreement covering most of its business was signed on 30 July 2025. Niederer Kraft Frey acts as lead counsel to GF on this transaction, following its earlier lead counsel role in connection with the divestment of GF’s Casting Solutions division to Nemak (announced in July 2025) and the divestment of GF’s Machining Solutions division to United Grinding Group (announced in October 2024). The NKF team is co-led by Transactions partners Philip Spoerlé and Andrea Giger and further comprises associates Carlotta Ulmer, Peter-Conradin Schreiber and Lorenzo Henseler (all Transactions), junior associates Leonard Reiter and Caterina Moor (both Transactions), partner Thomas Hochstrasser (Commercial), partner Nicolas Birkhäuser (Antitrust), as well as counsel Marc Vogelsang (Tax). NKF is supported by White & Case LLP with a team led by Stefan Bressler, Gernot Wagner and Rebecca Emory and comprising Maximilian Eichhorn (all Frankfurt).

Zurich, Switzerland, 30 December 2025 The Euronext-listed Synergie SE has signed an agreement to acquire a majority stake in House of Flexwork AG. House of Flexwork AG is a leading Swiss staffing agency operating under the brands Induserv, Hardworker and Payroll House, providing temporary and payroll services to a diversified client base. Bär & Karrer advises Synergie Group in this transaction. The team is co-led by Christoph Neeracher and Luca Jagmetti and further includes Ronny Schmid and Markus Mezger (all M&A), Susanne Schreiber, Donjeta Beka and Sandro Berchtold (all Tax), Manuel Schmid (Employment), Dominique Simmen (Financing), Ferdinand Rombach (Data Protection) and Corina Moschen (Real Estate). For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]

Omnidocs Group ApS (Denmark), a portfolio company of Main Capital Partners and a provider of document creation software, has acquired all shares in officeatworkAG. officeatwork AG is a provider of document creation solutions. Bär & Karrer acted as legal advisor to Omnidocs Group ApS (Main Capital Partners) in this transaction. The team was led by Raphael Annasohn and included Julian Lindt and Katarina Skoric (all M&A), Susanne Schreiber, Martin Leu, Alessia Suter and Christina Fricker (all Tax), Faton Aliu and Jorgos Boulamatsis (both Financing), Laura Widmer, Sandra Schaffner and Manuel Schmid (all Employment), Markus Wang and Christine Schweikard (both IP), Christian Kunz and Katharina Cardon (both Data Protection), Rocco Rigozzi and Corina Moschen (both Real Estate) and Julia Eiholzer (Notarial Services).

On December 21, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological diseases, announced a licensing agreement between its affiliate, LE2025 Therapeutics AG, and Qyuns Therapeutics Co., Ltd. for the development and commercialization of WIN027 (also known as QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13. Under the terms of the agreement, Windward Bio will gain exclusive rights to develop, manufacture, and commercialize WIN027 outside of China, for a total of up to USD 700 m in upfront and equity consideration and development and commercial milestones, as well as tiered royalties. The Homburger team advising Windward Bio includes Andreas Müller, Margrit Marti, Timo Hasler and Lucas Forrer (all Healthcare / Life Sciences and Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax) and other subject matter specialists.     Contact Gloria Pünchera / Marketing / [email protected]